Stockscreener 앱 받기
0.8701
1.67%
-0.0298
InspireMD Inc. 주식(NSPR)의 최신 뉴스
InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
InspireMD Q2 2026 Earnings: Revenue Misses $1.77 Million Estimate - Sci-Tech Today
Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $3 - Moomoo
NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance - Stocktwits
Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $4 - Moomoo
InspireMD total revenue down 0.4% to USD 1,771,000 in Q2 2026 - Medical Buyer
Form 8K InspireMD Inc For: 17 August By Investing.com - Investing.com South Africa
InspireMD Q2 revenue holds at $1.8 million - grafa.com
InspireMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
InspireMD Releases Q2 2026 Financial Results - AlphaStreet
Earnings call transcript: InspireMD Q2 2026 revenue miss weighs on shares - Investing.com Nigeria
InspireMD Inc reports results for the quarter ended June 30Earnings Summary - TradingView
symbol__ Stock Quote Price and Forecast - CNN
InspireMD reports Q2 2026 revenue $1.77M, net loss $14.3M; cash & marketable securities $30.4M - TradingView
InspireMD Reports $1.77 Million Q2 Revenue and $14.32 Million Net Loss - Quiver Quantitative
InspireMD (NSPR) recall turns U.S. sales negative — and deepens quarterly loss - Stock Titan
InspireMD Q2 Operating Expenses USD 13.671 Mi - Moomoo
InspireMD earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
InspireMD (NSPR) Surges 16.97% to $0.98, Pushing Toward Key ResistanceSentiment Shift - Vinanet
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Moomoo
InspireMD (NSPR) grows revenue 56% but flags going concern and Nasdaq risk - Stock Titan
InspireMD Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
InspireMD (NSPR) Dips 3.26% to $0.83, Pressing Against Key SupportVolatility Smirk - Vinanet
InspireMD (NSPR.US) is scheduled to release its financial report on August 17. - Moomoo
InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set - scanx.trade
InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results - Stock Titan
Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k - webull.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Approves 221,666 Restricted Shares for New Hire - Stock Titan
InspireMD Inc (NASDAQ: NSPR) Share Price, NSPR Stock News, NSPR Share Price & Updates - Kalkine
NSPR Q1 2026 Earnings: Narrower-Than-Expected Loss Sends Shares HigherReturn On Equity - Vinanet
InspireMD (NSPR) Gains 5.73% to $0.72, Pressing Toward Key Resistance at $0.76BPI Reversal - Vinanet
InspireMD (NSPR) Slides 3.68% to $0.65 as Key Support HoldsBullish Pattern Stocks - Vinanet
Piper Sandler Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $3 - Moomoo
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing - The Manila Times
InspireMD appoints Kathleen Kennedy as SVP of global sales By Investing.com - Investing.com Nigeria
Medical-device sales leader with more than 30 years returns to InspireMD - Stock Titan
InspireMD appoints Kathleen Kennedy as global sales head - scanx.trade
InspireMD, Inc. (NASDAQ: NSPR) eliminates chief commercial officer position - Stock Titan
NSPR|InspireMD Inc|Price:0.650|Chg%:-0.024 - TradingKey
InspireMD Inc (NSPR) Income Statement - TradingKey
InspireMD Inc (NSPR) Institutional Confidence - TradingKey
InspireMD Inc (NSPR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
InspireMD Inc (NSPR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InspireMD Inc (NSPR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
InspireMD Inc (NSPR) Cash Flow - TradingKey
NSPR|InspireMD Inc|Price:0.690|Chg%:+0.006 - TradingKey
InspireMD Inc. Revenue Breakdown – NASDAQ:NSPR - TradingView
InspireMD (NSPR) Edges Lower as Stock Tests Key Support Near $0.65Synthetic Long - Vinanet
InspireMD Inc. (NSPR) Q1 2026 Earnings: EPS Surpasses Estimates Despite Limited Revenue DisclosureGuidance Downgrade Alert - dars.gov.et
InspireMD Inc (NSPR) Valuation: PE, PB & Fair Value Analysis - TradingKey
InspireMD, Inc. Receives Notice of Delisting from NASDAQ – Form 8-K Filing July 2026 - Minichart
InspireMD Receives Nasdaq Minimum Bid Price Warning - Moomoo
InspireMD Receives Nasdaq Notice on Bid Price Compliance - The Globe and Mail
InspireMD Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
InspireMD (NSPR) warned by Nasdaq over $1.00 bid price and delisting risk - Stock Titan
1.35%
0.29%
자본화:
|
볼륨(24시간):